Mutant selection window hypothesis updated
K Drlica, X Zhao - Clinical infectious diseases, 2007 - academic.oup.com
The mutant selection window hypothesis postulates that, for each antimicrobial-pathogen
combination, an antimicrobial concentration range exists in which selective amplification of …
combination, an antimicrobial concentration range exists in which selective amplification of …
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid
S Kiem, JJ Schentag - Antimicrobial agents and chemotherapy, 2008 - Am Soc Microbiol
In spite of the development and wide use of antibiotics, pneumonia is still the leading cause
of infection-related mortality worldwide (101), and antibiotic resistance in the major …
of infection-related mortality worldwide (101), and antibiotic resistance in the major …
Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages
M Barcia-Macay, C Seral… - Antimicrobial agents …, 2006 - Am Soc Microbiol
The pharmacodynamic properties governing the activities of antibiotics against intracellular
Staphylococcus aureus are still largely undetermined. Sixteen antibiotics of seven different …
Staphylococcus aureus are still largely undetermined. Sixteen antibiotics of seven different …
Solar Photodegradation of a Novel des-F (6)-Fluoroquinolone, Garenoxacin, and Ecotoxicity of Its Phototransformation Products
S Huang, Z Zhang, C Lin, H Cheng - Environmental Science & …, 2024 - ACS Publications
Garenoxacin (GRNX) is a novel des-F (6)-fluoroquinolone on the horizon; thus, its fate and
risk in the aquatic environment deserve attention. This study systematically investigated, for …
risk in the aquatic environment deserve attention. This study systematically investigated, for …
Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones
JP Gisbert - Molecules, 2020 - mdpi.com
H. pylori infection is the main cause of gastritis, gastroduodenal ulcer disease, and gastric
cancer. Fluoroquinolones such as levofloxacin, or more recently moxifloxacin or sitafloxacin …
cancer. Fluoroquinolones such as levofloxacin, or more recently moxifloxacin or sitafloxacin …
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria …
C Seral, M Barcia-Macay… - Journal of …, 2005 - academic.oup.com
Objectives: Quinolones accumulate in eukaryotic cells and show activity against a large
array of intracellular organisms, but systematic studies aimed at examining their …
array of intracellular organisms, but systematic studies aimed at examining their …
Difluoromethylation of Phenols and Thiophenols with the S-(Difluo-romethyl)sulfonium Salt: Reaction, Scope, and Mechanistic Study
GK Liu, WB Qin, X Li, LT Lin… - The Journal of Organic …, 2019 - ACS Publications
A facile and practical approach for the difluoromethylation of phenols and thiophenols was
described. Making use of the recently developed bench-stable S-(difluoromethyl) sulfonium …
described. Making use of the recently developed bench-stable S-(difluoromethyl) sulfonium …
Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics
M Miftahussurur, H Aftab, PK Shrestha… - … Resistance & Infection …, 2019 - Springer
Abstract Background Nepal and Bangladesh have a high prevalence of Helicobacter pylori
with high resistance rates to clarithromycin, metronidazole, and levofloxacin. Here, we …
with high resistance rates to clarithromycin, metronidazole, and levofloxacin. Here, we …
Gateways to clinical trials.
M Bayes, X Rabasseda, JR Prous - Methods and findings in …, 2003 - europepmc.org
Gateways to clinical trials is a guide to the most recent clinical trials in current literature and
congresses. The data in the following tables has been retrieved from the Clinical Studies …
congresses. The data in the following tables has been retrieved from the Clinical Studies …
Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically I ll Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal …
RF Eyler, M Heung, M Pleva… - … : The Journal of …, 2012 - Wiley Online Library
Study Objective To investigate oseltamivir and oseltamivir carboxylate pharmacokinetics in
critically ill patients who were receiving continuous venovenous hemodialysis (CVVHD) …
critically ill patients who were receiving continuous venovenous hemodialysis (CVVHD) …